Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Payments (Tables)

v3.10.0.1
Stock-Based Payments (Tables)
9 Months Ended
Sep. 30, 2018
Stock-Based Payments  
Summary of status of stock options and changes during the period

A summary of the status of stock options as of December 31, 2017 and September 30, 2018 and changes during the nine months ended September 30, 2018 is presented below:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

 

    

 

 

    

 

    

Aggregate

 

 

 

 

 

Weighted

 

Remaining

 

Intrinsic

 

 

 

 

 

Average

 

Contractual

 

Value

 

 

 

Shares

 

Exercise Price

 

Life (in years)

 

(in thousands)

 

Outstanding at December 31, 2017

 

2,846,668

 

$

9.25

 

8.2

 

$

5,713

 

Granted

 

1,358,552

 

 

10.90

 

 

 

 

 

 

Exercised

 

(103,153)

 

 

4.73

 

 

 

 

 

 

Cancelled

 

(390,917)

 

 

10.95

 

 

 

 

 

 

Outstanding at September 30, 2018

 

3,711,150

 

$

9.80

 

8.1

 

$

9,358

 

Exercisable at September 30, 2018

 

1,354,815

 

$

7.50

 

6.7

 

$

6,505

 

 

Schedule of weighted-average assumptions used in Black-Scholes option-pricing model

The fair value of each stock option granted was estimated on the date of grant using the Black-Scholes option-pricing model based on the following weighted-average assumptions:

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30, 

 

Nine Months Ended September 30, 

 

 

 

2018

    

2017

    

2018

    

2017

 

    

Weighted-average risk-free interest rate

2.87

%  

2.04

%  

2.49

%  

2.03

%

 

Expected dividend yield

 -

%  

 -

%  

 -

%  

 -

%

 

Expected option term (in years)

6.08

 

6.08

 

6.03

 

6.01

 

 

Volatility

89.71

%  

90.84

%  

90.34

%  

87.22

%

 

 

Summary of stock-based compensation expense for stock options granted to employee and non-employees

The following table summarizes the stock-based compensation expense for stock options and restricted common stock granted to employees and non-employees recorded in the Company’s condensed consolidated statements of operations:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30, 

 

Nine Months Ended September 30, 

 

    

2018

    

2017

    

2018

    

2017

    

Research and development

    

$

550

    

$

443

    

$

1,785

    

$

1,221

 

General and administrative

 

 

987

 

 

665

 

 

3,192

 

 

1,927

 

Total stock-based compensation expense

 

$

1,537

 

$

1,108

 

$

4,977

 

$

3,148